China Radiodermatitis Market Size & Outlook, 2023-2030
China radiodermatitis market, 2018-2030 (US$M)
Related Markets
China radiodermatitis market highlights
- The China radiodermatitis market generated a revenue of USD 56.1 million in 2023 and is expected to reach USD 72.6 million by 2030.
- The China market is expected to grow at a CAGR of 3.8% from 2024 to 2030.
- In terms of segment, topical was the largest revenue generating product in 2023.
- Topical is the most lucrative product segment registering the fastest growth during the forecast period.
Radiodermatitis market data book summary
| Market revenue in 2023 | USD 56.1 million |
| Market revenue in 2030 | USD 72.6 million |
| Growth rate | 3.8% (CAGR from 2023 to 2030) |
| Largest segment | Topical |
| Fastest growing segment | Topical |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oral, Topical, Dressings |
| Key market players worldwide | Smith & Nephew PLC, Integra LifeSciences, ConvaTec Group PLC, 3M Co, Molnlycke Health Care, Alliqua BioMedical, Stratpharma, BMG Pharma |
Other key industry trends
- In terms of revenue, China accounted for 13.1% of the global radiodermatitis market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China radiodermatitis market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 51.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Radiodermatitis Market Scope
Radiodermatitis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China radiodermatitis market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to radiodermatitis market will help companies and investors design strategic landscapes.
Topical was the largest segment with a revenue share of 70.94% in 2023. Horizon Databook has segmented the China radiodermatitis market based on oral, topical, dressings covering the revenue growth of each sub-segment from 2018 to 2030.
According to a report published by The State Council Information Office of the People's Republic of China Urban Employee Basic Medical Insurance (UEBMI), Urban Resident Basic Medical Insurance (URBMI) or New Cooperative Medical Scheme (NCMS) cover more than 95% of the Chinese population under medical insurance.
Owing to the introduction of new medical insurance and reimbursement policies the radiodermatitis market is expected to grow during the forecast period in China. Owing to the development in economy and growing disposable incomes, China is expected to be the fastest growing market for radiodermatitis treatment.
Reasons to subscribe to China radiodermatitis market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China radiodermatitis market databook
-
Our clientele includes a mix of radiodermatitis market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China radiodermatitis market , including forecasts for subscribers. This country databook contains high-level insights into China radiodermatitis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China radiodermatitis market size, by product, 2018-2030 (US$M)
China Radiodermatitis Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
